Indeed, analyzing the frequency distribution of CD34+ progenitor cells (HSC, MPP, LMPP, MLP, CMP, GMP, MEP, B/NK) treated or not with AML EVs, we observed a differentiation deregulation. The gene discussed is CD34; the disease is acute myeloid leukemia.